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Abstract
Biomaterials including ceramic material, polymer material, metallic material and
composite material have been used in biomedical scaffolds, artificial tissues, and drug delivery
systems for a long time. Magnesium (Mg) and Mg-based alloys are a new generation of
degradable metallic materials that have attracted great attention in the last ten years. The
advantages of Mg alloys as biomaterials are their good biocompatibility and biodegradability.
Mg as an essential element in human body is an enzyme cofactor for over 300 biochemical
reactions. However, the degradation process of Mg material may hinder the potential application.
The purpose of this study is to evaluate the biocompatibility of pure Mg and Mg alloys by
different in vitro methods. We believe that Mg material could be used as vascular stent material
and bone orthopedic implant materials.
The effect of different metals used in Mg stent materials on endothelial cells,
biocompatibility of Mg-Rare Earth (RE) alloys, collagen self-assembly on Mg bone orthopedic
material, and endothelialization on hydrofluoric acid conversion coating were studied. Scanning
electron microscope, electrochemical corrosion test, hemolysis test, platelet adhesion test, cell
viability test, cell proliferation test, immunostaining and q-PCR were used. Major results
include: (i) the effect of Mg on endothelial cell viability and proliferation is dose-dependent; (ii)
alloying with rare earth elements could improve endothelial cell attachment and viability; (iii)
the structure of collagen self-assembly on Mg material is affected by collagen monomer
concentration, assembly time, pH, and degradation products; and (iv) hydrofluoric acid
conversion coating can improve endothelial cell attachment and proliferation. This study
successfully shows that Mg alloys have the potential to be medical implant materials.
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CHAPTER 1
Introduction
1.1 Biomaterials
A biomaterial is any substance, natural or man-made, that is used to help the biological
system to fulfill its function or to induce the system to recover from certain defects. Since the
late 18th century, biomaterials have been used in joint replacements, bone plates, bone cement,
artificial ligaments, artificial tendons, dental implants, blood vessel prostheses, heart valves,
cardiovascular stent, and artificial skin [1,2]. There are three development stages for
biomaterials: inert biomaterial, resorbable biomaterial, and regenerative biomaterial [3]. For inert
biomaterial, its function is mainly to maintain local system integrity and there is limited tissue
response. Resorbable biomaterials can be degraded and absorbed by local tissues over a certain
amount of time. Regenerative biomaterial should not only have the basic characteristics of a
biomaterial but also be able to induce and promote the self-healing of the tissue. Based on the
material composition, the most common classes of biomaterials include ceramic material,
polymer material, metallic material, and composite material.
Polymer biomaterial has some unique properties such as flexibility, preferable
biocompatibility, light weight and an adjustable range of physical and mechanical properties.
Polymer materials can be divided into two categories based on their origin: artificial polymer and
native polymer. Polytetrafluoroethylene (PTFE), Dacron (PET) and polyglycolic acid (PGA) are
the most commonly used synthetic materials in vascular grafts [4-6]. Among them, synthetic
poly (ethylene terephthalate) (Dacron) and expanded polytetrafluoroethylene (ePTFE) have been
successfully used for reconstruction of peripheral arteries in large diameter vascular grafts.
Besides vascular graft, polymer materials are also used in artificial skin, artificial heart valve,
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vascular stent and drug delivery system. Generally, ceramic biomaterial and metal biomaterial
are often chosen for hard tissue applications because of their relative higher mechanical strength
compared with polymer biomaterials. On the other hand, polymer has better biocompatibility
compared with metal and ceramic materials.
Ceramic biomaterials are also called bioceramics. Common ceramic biomaterials include
aluminia, zirconia, and bioglass. The major characteristics of ceramic biomaterials are high
hardness, brittleness, and high corrosion resistance. Ceramic biomaterials have been used in
several different biomedical applications such as dentistry, orthopedics as well as medical
sensors.
Metallic biomaterial usually has very strong mechanical strength. Titanium, titanium
alloys, stainless steel, nitinol, and cobalt alloys are called permanent metallic materials due to the
fact that their corrosion rate in physiological conditions is very slow. Biodegradable metallic
materials are a new generation of metallic biomaterials which can be degraded and absorbed by
the host. In many cases, biomaterials or medical implants do not need to be present after the local
tissue has healed. Therefore, another surgery is needed to remove the medical devices made by
permanent materials. Degradable metallic materials can avoid another surgery to remove the
medical devices. Iron, zinc, zinc alloys, magnesium (Mg), and Mg alloys are currently
extensively researched for degradable biomaterials.
1.2 Mg and Mg Alloys
Mg is a very attractive biodegradable material which has very good biocompatibility and
low thrombogenicity [7]. Mg also is an essential element in human body required for many
biological/metabolic activities. In addition, Mg ion is the cofactor for many enzymes and pure
Mg can be easily degraded in simulated body fluid and lose the mechanical strength. The
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degradation products of Mg alloys may include metal ions, metal particles, and hydrogen gas,
which all might hamper the biocompatibility of Mg materials. Mg alloyed with Al, Zn, Ca,
Zirconium (Zr), Yttrium (Y), and rare earth elements (REs) can significantly improve the
corrosion resistance and mechanical strength. Mg and its alloys are often used for vascular stent
and bone orthopedic application [8].
1.3 Mg Stent
Vascular system disease including cardiovascular disease, cerebrovascular disease, and
peripheral arterial disease is the leading cause of mortality in the United States. Currently about
30% of global death is caused by cardiovascular disease [9]. Cardiovascular stents have been
used to treat vascular stenosis for a long time. Dozens of biomaterials have been tried to
demonstrate their ability as a suitable candidate for the stent material, such as stainless steel,
nitinol, cobalt alloys, titanium alloys, Mg-based alloys and polymers. Enough mechanical
strength until tissue heals, high corrosion resistance and good biocompatibility are the three
major requirements for a suitable stent material. The key advantage of Mg-based material over
others for stent material is its potential to reduce or even eliminate the late restenosis which
occurs very frequently in permanent stent materials. Despite the advantages of Mg-based stent,
high corrosion rate and low mechanical strength are two major limitations for stent application.
Alloying with other metal elements and surface coating are used to conquer the two problems.
The first biodegradable metallic stent was based on Mg by Armco Iron and implanted in an
animal model in 2001 [10]. Figure 1 shows a vascular stent based on Mg alloy [11].
Endothelialization is a key factor for successfully stent implantation. Therefore, it is very
important to study how Mg and Mg degradation products interact with vascular endothelial cells.
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Figure 1. Mg based cardiovascular stent [11].
1.4 Mg for Orthopedic Application
Metallic biomaterials play an important role in repairing or replacement of diseased or
damaged bone tissues because of their suitability for load-bearing. There are several advantages
of Mg-based alloys for bone orthopedic application over other metal biomaterials, e.g., stainless
steel, titanium alloys, and cobalt-chromium alloys. First, their physical and mechanical
properties including density (1.74-2.0 g/cm3), elastic modulus (41-45 GPa), and compressive
yield strength (65-100 MPa), are much closer to that of natural bone, and therefore can avoid the
stress shielding effect [12-14]. Table 1 summarizes the physical and mechanical properties of
some implant materials with comparison to natural bone [15]. Second, Mg is an essential element
for many biological activities including enzymatic reaction, formation of apatite, and bone cells
adsorption [16]. Third, Mg alloys can eliminate the necessity of a second surgery to remove the
permanent bone implants. A lot of studies have shown that Mg implant materials had better bone
cell induction compared with other biomaterials [15,17-19]. However, how Mg material interacts
with extracellular matrix (ECM) in bone tissues is still unknown. ECM plays an important role in
the structure and function of bone tissues. Therefore, it is very important to study how Mg
materials affect the ECM structure and their functions.
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Table 1
Summary of the physical and mechanical properties of some orthopedic biomaterials with
comparison to natural bone [15]
Properties
Density (g/cm3)
Elastic modulus (Gpa)
Compressive yield strength
(Mpa)
Fracture toughness (MPam1/2)

Natural
bone
1.8–2.1

Mg

Ti alloy
4.4–4.5

3–20
130–180

1.74–
2.0
41–45
65–100

3–6

15–40

110–117
7581117
55–115

Co–Cr
alloy
8.3–9.2

Stainless
steel
7.9–8.1

230
450–1000

189–205
170–310

N/A

50–200

1.5 Thesis Outline
Chapter 2 will be a literature review of current research focus of Mg and Mg-based
biomaterials, popular methods used for assessing the biocompatibility, potential applications for
tested materials, and coating materials for Mg. Chapter 3 will discuss methods and materials
used to evaluate the toxicity of Mg degradation products, biocompatibility of Mg materials, and
coatings for Mg. Chapter 4 will discuss all results regarding the material characterization,
biocompatibility of the materials, and surface coating. Lastly, chapter 5 presents a summary of
the results discovered and suggested future studies.
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CHAPTER 2
Literature Review
The history of application Mg as a degradable biomaterial dates back to late 19th century.
Lambotte reported the first use of Mg as a plate to secure a fracture involving the bones of the
lower leg [20]. Due to the fast corrosion rate of pure Mg in vivo, the trial failed only 8 days after
the surgery. In 1944, Troitskii and Tsitrin reported a study where Mg alloying with cadmium was
fabricated into plates and screws and used to secure bone fractures [21]: 25 of 34 cases were
successfully implanted and no inflammatory reaction or high serum magnesium level was
observed. In 1986, Richard Jorgensen filed a patent on a Mg device for haemostatic clip; he
found that Mg clips and staples were safer for closing vessels in brain or deep wounds [22]. Later
in the 20th century, Mg was researched as biodegradable cardiovascular stent and orthopedic
biomaterials. During the recent 10 years, there is a boom of study of Mg-based alloys.
2.1 Alloying Elements.
Pure Mg has very fast degradation rate and lower mechanical strength. Those two
properties can be improved by alloying with other metal elements. Al, Zn, Ca, Mn, Zr, Y and
rare earth elements (REs) are the most common elements used in Mg alloys. Table 2 summarized
the composition of some commercially available Mg alloys and alloys that were widely studied
recently. The mechanical properties and corrosion resistance could be improved by aluminum
significantly [23]. However, excessive aluminum ions have a high toxic effect on nervous system
[24]. Zn a nd Ca are two common necessary elements in human body and it is believed that Zn is
one effective element for improving the mechanical strength of Mg-based alloy [25]. In addition,
Zn and Mn can also enhance the corrosion resistance by avoiding the galvanic corrosion caused
by nickel and iron impurities [25].
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Table 2
Composition of different Mg-based alloys

Alloy

AZ31

Mg
Balan
ce
Bal

ZW21

WE43

Al
/

Elements Percentage (wt%)
Zn
Ca
Mn
Zr
0.2
/
0.13
0.36

Referen
ce
[26]

Re
3.8

Other
Y:4.16

[27,28]

2.83

0.8

/

0.37

/

/

Bal

/

2

0.15

/

/

AZ31B
AZ63

Bal
Bal

1.2
5.6

0.74
2.7

0.2
5
/
0.2

Si:0.1~0.
05
Y:1

/
/

/

Si:0.026
Cu:0.2

[30]
[31]

AZ91D
Mg-Sr

Bal
Bal

0.6
/

/
/

/
/

/
/

Bal

/

Bal

/

/

/

/

[34]

Mg-Li-AlRe
Mg-Nd-ZnZr
Mg-Nd-ZnZr
Mg-Zn-YNd
Mg-Al-CaMn

Bal

2-4

/

4~
5
/

1.08~1.
11
/

/

Mg-Zn-Ca

1.05~3.
05
30~25

Cu:0.25
Sr:0.3~2.
5
/

[32]
[33]

Mg-Mn-Zn

8.5
0.007~0.0
12
<0.3

0.35
0.18~0.
5
0.25
0.003

/

/

2

[35]

Bal

/

0.164

/

0.003

Bal

/

0.22

/

/

0.41
3
/

/

[37]

Bal

/

2

/

/

/

3.1
3
3.5
3
0.5

Li:3.5~8.
5
/

Y:0.46

[38]

Bal

3.5

/

3.3

0.4

/

/

/

[39]

[29]

[25]

[36]

One of the most attractive approaches today in fabricating new Mg-based alloy is to add
rare earth elements (Sc, Y, and all lanthanides) to the alloy system [40]. On the other hand, their
toxicity is still controversial and remains as a main concern. Nd, Gd, Y, and Er are the most
commonly used REs. Besides WE43, AZ31 and other commercial Mg alloys, the mechanical
strength, corrosion behavior and biocompatibility of Mg-Y, Mg-Nd-Y, Mg-Zn-Y, Mg-Zn-Y-Nd,
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Mg-Nd-Zr, Mg-Nd-Zn-Zr were extensively investigated [37,41-45]. Seitz et al. tested cell
viability and cell proliferation after exposure to the Mg-Nd degradation solution, and their results
indicated that alloying with Nd did not affect the cell viability [46]. Murine aneuploid
fibrosarcoma cell line(L-929) cells cultured with extracts from Mg-1.5Y-1.2Zn-0.44Zr showed
that there was improved cell proliferation with no significant cytotoxicity [47]. In vitro cell
culture with rare earth chlorides showed that most rare earth elements have obvious effect on
viability of human umbilical cord perivascular cell at concentrations over 1000 µg/mol [48].
However, it is still unclear whether REs released from stent will affect the endothelialization
process.
2.2 Material Preparation and Characterization.
The grain sizes of the alloys, second-phase distribution, mechanical properties as well as
absence of structural defects are strongly related to the processing routes. Pure Mg and other
alloying elements are typically melted and cast under an inert environment. As-casted alloys
often have an inhomogeneous grain structure, which results in lower mechanical strength and
fast corrosion at the grain boundary. Zhang et al. estimated the effects of extrusion and heat
treatment on the Mg-based alloy system [36]. It was shown that extrusion can significantly
improve the mechanical properties of the alloy by grain refinement and precipitation
strengthening. In addition, the mechanical properties decreased as the increase of the extruded
temperature (250-450ºC). It was also shown that cyclic extrusion compression could optimize the
microstructure and corrosion behavior of Mg–Zn-Y-Nd alloy compared with as-cast and
extrusion alloys [49]. After extrusion of ZM21 alloy, the grain size was within submicrometer
range and the hardness was significantly higher than that of the coarse-grained ZM21 alloy [50].
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Annealing can significantly improve the elongation of Mg-Zn-Y alloy, but the yield strength
ofthe alloys with different contents decreases [51].
Table 3
Mechanical properties of Mg alloys
Alloy name

Pure Mg
WE43
AZ31B
AZ91D
ZM21
Mg-Sr
Mg-Li
Mg-Zn-Ca
Mg-Zn-Y
Mg-Li-Al
Mg-Mn-Zn
Mg-Li-AlRe
Mg-Nd-ZnZr
Mg-Zn-YNd
Mg-Zn-YNd
Mg-Al-CaMn

Fabrication

Grain
size(middle
linear
length um)
As-rolled
/
As-extruded
10~30
As-extruded
/
Die-cast
250
As-extruded
0.52~15
As-casted
5~30
As-extruded
As-casted
/
As-extruded
3~4
As-extruded
As-extruded
4~9
As-extruded
/

Yield
strength(MPa)

UTS
(Mpa)

Elongation Reference
(%)

113
216.67
200
70.67
180~340
/
~70
/
160
~90
246
73~130

170
297.67
255
170.74
259~353
210~240
101~148
162
270
~148
280
200~230

12
21.67
12
4.3
/
/
75~190
/
20
~220
20
15~46

[31]
[52]
[53]
[52]
[50]
[54]
[35]
[55]
[56]
[35]
[25]
[35]

As-extruded

/

124~189

226~243

17~26

[36]

As-casted

/

105

209

10.6

[49]

As-extruded

5~15

185

316

15.6

[49]

As-extruded

/

/

420

5.6

[39]

Mechanical properties are always the top priority when a new alloy is evaluated as stent
material. Yield strength, ultimate tensile strength and elongation are the three most common
factors to determine if the material could fulfill its function with respect to a mechanical
perspective. In addition, for most balloon expandable stents, 20% to 30% elongation is needed
for the stent expansion process. Table 3 summarizes the mechanical strength of some Mg alloys.
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Immersion test, electrochemical corrosion test, and in vitro cell culture were often used to
determine the corrosion property and biocompatibility. Immersion test in solution can provide a
simplified model about how stent materials degrade in a static solution. Table 4 summarizes the
immersion corrosion parameters of different alloys. Sample size and corrosion solution in
different experiments varied, which could have direct effects on the corrosion rate. It is the same
scenario for electrochemical corrosion tests (Table 5). Electrochemical impedance spectroscopy
and potentiodynamic polarization showed dominant role in revealing Mg-alloy galvanic
corrosion.
Table 4
Immersion degradation test of Mg material
Alloy name
WE43
ZW21
MgSr
MgLi
MgLiAl
MgMnZn
MgLiAlRe
MgNdZnZr
MgNdZnZr
MgZnYNd
MgZn

Size/mm
D=8,T=1.5
D=17.5,T=3.6
H=40,W=20,T
=6
D=10,T=2
D=10,T=2
D=11.3,T=2
D=10,T=2
D=12,T=5
D=12,T=5
D=8,T=5
D=11.3

solution

Corrosion rate
(mg/d*cm2)
0.363
/
2~23

Reference

SBF,APS
SBF
Hank’s

Duration/
d
5,10
7
1~3

Hank’s
Hank’s
SBF
Hank’s
SBF
APS
SBF
0.9%NaCl

3~10
3~10
3~30
3~10
10
10
5
3~6

/
/
/
/
0.09~0.14
0.337mm/y
4.8~8.04
1.5~3.9

[35]
[35]
[25]
[35]
[36]
[57]
[49]
[58]

[26,37]
[29]
[33]

2.3 Surface Modification.
The most effective way to improve the corrosion resistance and biocompatibility of stent
materials without compromising their mechanical strength is surface modification. Surface
treatment and surface coating are the two common strategies. The difference between them is
that surface treatment does not add any distinctive layer of substance and it only modifies the
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composition or microstructure of the outer layer. Some of the techniques that have been
commonly used for stent surface modification include galvanization, sputtering followed by ion
bombardment, pulsed biased arc ion plating, micro-arc oxidation, dipping, spraying, and plasmabased deposition [59-66].
Table 5
Electrochemical corrosion tests of Mg alloys
Alloy
name
Pure Mg
AZ31
AZ31B
WE43
MgLiAl
Re
MgZnCa
Mg0.5Sr
MgZnY
Nd
MgNdZn
Zr
MgZnY
MgLi
MgLiAl

Shape

Area(cm2)

Solution

Icorr(mA/cm2)

Ecorr(V)

Square
Round
/
Round
Round

1
0.785
/
1
0.785

Hanks
PBS
SBF
SBF
Hank’s

0.0598
0.182
0.0013
0.509
0.418~1.412

Square
/

1
0.72

SBF
Hank’s

0.11
0.005

-1.554
-1.54
-1.69
-1.85
-1.482~1.587
-1.645
-1.58

Round

1

SBF

1.08

Round

1

APS

/
Round
Round

1
0.785
0.785

SBF
Hank’s
Hank’s

Degradation Referenc
rate(mm/y)
e
[31]
/
[67]
/
[30]
/
[26]
0.1~3.4
[35]
/
0.2~0.4

[55]
[33]

-1.7

/

[38]

0.00141

-1.69

/

[57]

0.44
0.428~0.461
-1.587

-1.792
-1.52~-1.565
0.418

/
0.1~0.16
0.1

[56]
[35]
[35]

Mg alloy coated with PLGA by dipping method was tested by Li et al. [58]; their
immersion and potentiodynamic tests showed that coating with PLGA can significantly reduce
the corrosion rate. Besides, osteoblast cells demonstrated good morphology and spread well on
the coated Mg samples. In contrast, there was no cell attachment observed on the bare Mg
surface. In another study, PLA and PCL layer of 15 to 20 µm were coated on the high purity Mg
surface [68]. PLA and PCL coated Mg had higher free corrosion potentials and smaller corrosion
currents. In addition, the weight loss and surface characterization showed that the interaction
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between polymer and the Mg surface may undermine the corrosion resistance of coated high
purity Mg. Moreover, adhesion of pyrrole to the AZ31 surface could reduce the corrosion
potential and corrosion current, indicating good corrosion resistance compared with bare AZ31.
Wang et al. compared the poly(1,3-trimethylene carbonate) (PMTC) and PCL as coating
materials on the Mg-Mn-Zn alloy surface [69]. The static and dynamic hemocompatibility test
showed that platelets, red blood cells and leukocytes attached on the PMTC coated Mg were
much less than that on the 316 stainless steel, PCL coated and bare Mg. Electrochemical
corrosion test, dynamic degradation test and in vivo degradation test all demonstrated that the
PMTC coated Mg had higher biocompatibility.
Table 6
Effect of some coatings on the corrosion of Mg alloys
Alloy

AZ31
WE43
WE43
AZ91D
Mg-Zn-Ca
Mg-Zn-Y-Nd
Mg-Zn
AZ91D
AZ91E
MgZnMn
MgZnMn
MgNdZnZr

Material

Fluoride
Phytic acid
SiC
Ceramic
Hydroxyapatite
Ti-O
PLGA
Zr power
Gold
PTMC
PCL
Hydrofluoric
acid

Ecorr(V
,
uncoat
ed)
-1.57
-1.85
4.9
-1.75
-1.645
-1.70
-1.46
-1.584
~-1.72
-1.694
-1.694
-1.69

Ecoor(V,coat
ed)

-1.54
-2.80~-1.79
0.6
-1.61~-1.39
-1.414
-1.65
-1.44~-1.36
-1.422
~-1.31
-1.478
-1.604
-1.59

Icorr
(uA/cm2
,uncoate
d)
1820
509
/
37.1
110
1080
26.5
607900
~91
190546
190546
1.41

Icorr
(uA/cm2,coate
d)

Reference

209
3070~508
/
0. 08
25
48
0.085
200.4
~82
15.1
1625.5
1.05

[71]
[26]
[26]
[72]
[55]
[38]
[58]
[73]
[74]
[69]
[69]
[57]

Xiao et al. coated the die-cast AZ60 with calcium phosphate [70]. The uncoated and
coated alloys were implanted into rabbit femora. The mean weight loss of coated and uncoated
alloy was 0.12 g and 0.21 g at one month respectively. CT data showed that the in vivo
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degradation rate of the uncoated alloy is almost 3 times as high as that of the coated alloy. Wang
et al. treated the AZ31 surface with hydrofluoric acid and sulfuric acid to form a
superhydrophobic layer [67]. The corrosion current of the AZ31 coated with hydrophobic layer
is a tenth of that of the bare AZ31. Superhydrophobic surfaces had less platelets adhesion after
incubated with blood for 1 h. Yang et al. immersed the AZ31B in fluoric acid of 50wt% from 3
to 168 h [30]. A compact film with several irregularly distributed pores was observed on the
surface of alloys. Besides, as the immersion time increases, the corrosion resistance of the treated
sample also increases. Other coating materials in recent studies were summarized in Table 6.
2.4 Preclinical and Clinical Evaluation of Mg Materials.
In vitro biocompatibility tests include direct cell culturing on the Mg material surface,
cell viability test, cell proliferation test, hemolysis test and platelet adhesion test. Those tests can
provide data to evaluate the potential for further in vivo and clinical tests. 3-(4, 5dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) test has been the most commonly
used method to test cell viability in characterizing the cytocompatibility of Mg alloys. This test is
based on the detection of NAD(P)H-dependent cellular oxidoreductase enzymes. Other methods
to test the cytocompatibility include MTT, Lactose dehydrogenase (LDH), Bromodeoxyuridine
(BrdU), and adenosine triphosphate (ATP)-based tests [75,76]. Hemolysis test and platelet
adhesion test are usually used to test the hemocompatibility of the material. Table 7 shows the
effect of different alloys on cell viability and hemolysis. Animal models including dog, rabbit
and pig models were used for preclinical test (Table 8). For example, sirolimus-eluting stent
made from AZ31B was tested in the infrarenal abdominal aorta of rabbit [79]. Radiographs
showed that most of the stent struts remain complete after 30 days implantation but fully
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degraded after 120 days, suggesting that the corrosion resistance of Mg stent still needs to be
improved.
Table 7
In vitro biocompatibility test of Mg alloys

Alloy

Cell viability(indirect)
Cell line
Duration(d)-viability(%)
WE43
L929
1- ~28
2- ~32
4- ~32
WE43
L929
1-83
3-69
5-67
Mg-3.5Li
VSMC
1-130
3- ~80
5- ~80
Mg-3.5Li
ECV304
135Coated-WE43
L929
1-83
2-87
4-96
MgZnCa
L929,MG63
1-83
3-52
5-52
MgMnZn
/
/
/
/
MgLiAl
VSMC
1- ~182
3- ~98
5- ~90
MgLiAl
ECV304
1- ~92
3- ~75
5- ~87
MgY
VSMC
2-92
4-120
7-89
MgZn
L929
2-~97
4-~96
7-~96
Mg-0.5Sr
HUVEC
1-75
4-102
7-112
Mg-8.5Li-Al-Re VSMC
1- ~105
3- ~75
5- ~60
Mg-8.5Li-Al-Re ECV304
1- ~42
3- ~48
5- ~69
MgNdZnZr
Endothelia
1- 95.4
3-102.2 5- ~120
cell

Hemolysis

Reference

9.27
4.9
2.6~3.75
2.6~3.75
3.57
/
0.48
3.75
3.75
5
/
/
6
6
52

[26]
[26]
[35]
[35]
[77]
[34]
[25]
[35]
[35]
[31]
[78]
[33]
[35]
[35]
[57]

PROGRESS-AMS was the first clinical trial of absorbable Mg metal alloy stents where
63 patients received the stent implants [80,81]. The length and diameter of the stents ranged from
10-15 mm and 3-3.5mm. After implantation, the patient follow-up was scheduled at 4, 6, and 12
months. Coronary angiography and intravascular ultrasound showed that the lumen loss at 4
months was 0.83 mm. Mg was replaced by calcium and phosphorous compound within 2
months. A continuation of such clinical trial was published later where the long-term effects of
Mg stent in human body was evaluated by angiogram and IVUS [82]. Eight patients who were in
good condition after 4 months implantation were selected in this study. The net volume
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obstruction was about 11% (1.3-18.2 mm3) after 12 months implantation and the stent volume
reduced from 124.5 mm3 to 94.2 mm3.
Table 8
Animal models used for in vivo evaluation of Mg alloys
Alloy

Stent(mm)
Length Diameter Strut thickness
WE43
10
2.4
0.27
WE43
10
1.2
0.15~0.2
AZ31B
15
3
0.155
Mg0.5Sr
AZ31B
AE21

Animal

Position

dog
pig
rabbit

Femoral artery
Coronary artery
Infrarenal
abdnominal aorta
Femoral artery

21
10-56
30-120

[33]
[83]
[84]

21

[33]

Carotid artery
Anterior,circumflex
and coronary artery

30~120
10~56

[79]
[85]

10

2.4

0.27

dog

15
10

3
2

0.155
0.12-0.2

rabbit
pig

Duration(d) Reference

The first-in-man trial of the drug-eluting absorbable metal stent based on Mg alloy was
reported recently [86-88]. The stent used in this clinical trial was balloon-expandable, paclitaxeleluting delivery system based Mg alloy. The study was carried out in 5 clinical centers including
47 patients and the clinical follow-up for the patients was arranged at 1, 6, 12, 24, and 36 months
respectively. All the stents were successfully delivered to the location of lesion and the clinical
follow-up ratio at 1 month, 6 months, 12 months are 100%, 100%, and 93%, respectively [87].
Except for one patient who died from non-cardiac cause and for 2 patients who withdrew their
informed consents, data was collected from the rest of the patients. The luminal cross-section
area loss at 6 and 12 months are 1.12 and 1.30 mm2. This study first demonstrated the feasibility
of application of Mg-based biodegradable stents in clinical treatment.
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CHAPTER 3
Methodology
3.1 Material Preparation
3.1.1 Mg alloy. Mg based alloys of MgYZr-1RE, MgZnYZr-1RE (RE includes Gd and
Dy, denoted as R1 and R2, thereafter), as well as MgZnCaY-xRE (x=1 and 2, RE includes Nd
and Gd, denoted as R3 and R4, thereafter) were prepared by melting 99.97 % Mg ingot (Alfa
Aesar, US), 99.9 % Zn, Ca granules (Sigma-Aldrich, US) and Mg-30RE master alloys in an
electrical resistance furnace (Mbraun, US) under the protection of argon gas. Mg-30RE is a gift
from Institute of Metal Research, Chinese Academy of Science. The alloy fabrication process
was carried out by Dr.Zhigang Xu [89].
All the materials were then cut (Techcut 5, Allied High Tech Products, US) into 10×10×1
mm square and polished (EcoMet 250 Grinder, Buehler, US) with SiC paper up to 1200 grit. All
samples were supersonically cleaned (M2510 Ultrasonic cleaner, Branson, US) in absolute
acetone and ethanol (Sigma-Aldrich, US). For hemocompatibility and endothelialization tests,
each side of the samples was sterilized by UV light (1380 Biological Safety Cabinet, Thermo,
US) exposure for 30 min. At least 3 replicates were used in each experiment (n≥3).
3.1.2 Mg extracts solution. Mg extracts were prepared according to ISO 10993-12 [90].
Samples were soaked with serum free endothelial culture media (ECM, ScienCell, USA) as the
extraction medium with a ratio of 1.25 ml/cm2 in a humidified atmosphere with 5 % CO2 at 37
°C for 3 days. The supernatant was removed, filtered by a double layer 0.8 µm filter (BD
Biosciences, US) and refrigerated at 4 °C.
3.1.3 Ion stock solutions. The chlorides of Sodium (Na), Mg, Ca, Zn, Al, Y, Dy, Nd, and
Gd (>99.99 %, Sigma Aldrich, USA) were dissolved into deionized water at concentration of 1
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M (Na, Mg, Ca) and 0.01 M (The rest). The stock solutions were filtered, and stored at 4°C.
Final ion solutions were made by mixing stock solution with ECM.
3.2 Mg Material Characterization
3.2.1 Electrochemical corrosion. Potentiodynamic polarization curves were measured
by Gamry instruments (Gamry Ref 600, Gamry Instruments, US) using a three-electrode cell as
described previously [30]. The reference electrode, counter electrode and working electrode were
saturated calomel, platinum and testing materials. Tests were carried out in Hank’s balanced
solution (HBS, Invitrogen, US) after samples were immersed for a while. All the DC polarization
data was fitted and analyzed by Echem Analyst 6.0 (Gamry instrument, US). The corrosion rate
of all the samples were calculated according to ASTM-G102-89 [91].
3.3 In Vitro Biocompatibility
3.3.1 Hemolysis. Fresh human whole blood with sodium citrate was purchased from
Cedarlane Labs (Cedarlane, US). The test was performed according to the method described
previously [28]. In brief, 0.2 ml diluted human whole blood (4:5) was added to 10 ml centrifuge
tubes after all the samples were pre-soaked into 10 ml Dulbecco’s Phosphate Buffered Saline
(DPBS, Invitrogen, US) for 1 hour. The positive and negative groups were diluted blood with 10
ml deionized water and diluted blood with 10 ml DPBS, respectively. Then all the samples were
incubated at 37 ºC for 1 hour. After centrifuge (Biofuge Stratos, Thermo, US) at 800 g for 5 min,
the supernatants were collected and the absorbance (A) was measured using a UV-Vis
Spectrometer (Thermo, US) at 545 nm. The hemolysis rate (HR) was calculated by the following
equation:

① HR = [A(sample) - A(negative)]/[A(positive) - A(negative)].
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3.3.2 Platelet adhesion. Platelet rich plasma (PRP) with platelets of 108/ml (All Cells,
US) was used for platelet adhesion test. All the samples were pre-soaked in DPBS for 1 hour.
Then 100 µl PRP was overlaid on the surface of each sample and incubated (Heracell 150 I,
Thermo, US) at 37 °C for 1 hour. Samples were gently rinsed by DPBS for 3 times to remove the
non-adherent platelets. After that, 4 % paraformaldehyde (Boston Bioproducts, US) was used to
fix the adherent platelets followed by ethanol gradient (50 %, 60 %, 70 %, 80 %, 90 %, and 100
%) dehydration for 10 minutes. All the samples were coated by gold nanoparticle for 2 min and
observed by SEM (SU8000, Hitachi, US). The number of adherent platelets was counted by
Image-Pro Plus 6.0 (Media Cybernetics, US) on at least four different SEM images for each
sample.
3.3.3 Indirect cytocompatibility. Human aorta endothelial cells (HAEC) were purchased
from Sciencell Research Laboratories (California, US). HAECs were expanded ECM with 10 %
fetal bovine serum (Sciencell, US), 100 U/ml penicillin (Sciencell, US) and 100 µg/ml
streptomycin (Sciencell, US) on the fibronectin coated 75-flasks (BD Biosciences, US) at 37 ºC
in humidified incubator with 5 % CO2 and the passages 4-5 were used. Indirect MTT
(Invitrogen, US) test was used to measure cell toxicity. HAECs were seeded in the 96-well cell
culture plate (BD Bioscience, US) for 24 hours to allow cell attachment. ECM then was replaced
by 100 µl 10 %, 25 %, 50 %, and 75 % extract solutions. The positive control and negative
control were serum free ECM and serum free ECM with 10 % DMSO (Invitrogen, US),
respectively. After incubating in the humidified incubator for 2, 4, and 7 days, MTT test was
performed according to the manufacturer’s protocol. The absorbance (A) was measured at 570
nm by a Microplate reader (SpectraMax, Molecular Devices, US). Morphology of cells was
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characterized by Digital Inverted Microscope (EVOS, Advanced Microscopy, US). Cell viability
was calculated by the following equation:

② Viability= (Asample-Anegative)/(Apositive-Anegative)
3.3.4 In vitro direct endothelialization. Mg alloy samples were soaked into serum free
ECM for 3 days in 24-well culture plate (BD Bioscience, US) before using. Cell suspension (100
µl) with density of 100,000 cell/100 µl was overlaid on the surface of samples. Fibronectin
coated tissue culture plates were used as a control group. Cells were allowed to settle for 30 min
in an incubator with 5 % CO2 at 37ºC. DPBS was used to gently wash the sample surface for 3
times to remove the unattached cells. And then 2 ml serum free ECM was added to each well.
After 3 hours and 24 hours, Mg samples were transferred to another new plate and cells on the
sample surface were characterized by LIVE/DEAD Viability Kit (Invitrogen, US) according to
the manufacturer’s protocol. Images were taken by Digital Inverted Microscope (EVOS, US).
3.3.5 Effect of metal ions on cell viability. HCAECs were seeded in the 96-well cell
culture plate (BD Biosciences, USA) with 5,000 cells/well for 24 hours to allow cell attachment.
ECM was replaced by ECM supplemented with different ion solutions and incubated for 24
hours. ECM with 10% DMSO (Life Technologies, USA) and ECM alone were positive and
negative controls. Another blank reference containing same concentrate of ion solution without
cells was used to exclude the interference of the ions. MTT test was performed according to the
manufacturer’s protocol. Absorbance (A) was measured at 570 nm by a microplate reader
(SpectraMax5, Molecular Devices, USA). Cell viability was calculated by the following equation
(except for the Calcium group in which Ablank was not deducted):
③ Viability = (Asample-Anegative -Ablank)/(Apositive-Anegative)
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3.3.6 Lactate dehydrogenase release. HCAECs were seeded in 96-well cell culture plate
at 5,000 cells/well and incubated for 24 h. Then ECM was replaced by ECM supplemented with
different ion solution. After 24 h incubation, 100 μl culture media from each well was transferred
to a new plate for lactate dehydrogenase (LDH, Roche Applied Science, USA) test. Absorbance
was measured by a Microplate Reader (BioTek, USA) at 490 nm. Positive control and negative
control were cells cultured with ECM supplemented with 2.5% dimethylsulfoxide (DMSO, Life
Technologies, USA) and ECM, respectively. LDH release was calculated by the following
equation:
④ LDH = (Asample-Anegative)/(Apositive-Anegative)
3.3.7 Cell proliferation. BrdU cell proliferation kit (Cell Signaling, USA) was used for
cell proliferation test. HCAECs were seeded in 96-well cell culture plate at 5,000 cells/well.
After 24 hours, ECM was replaced by different ion solutions and incubated for 24 hours. The ion
concentration was set up to the concentration at which cell viability was not significantly
affected. Proliferation test was performed according to the manufacturer’s protocol. Absorbance
was measured at 450 nm. Positive control and negative control were ECM without ion
supplement and ECM without cells. Proliferation rate was calculated as following equation:
⑤ Proliferation = (Asample-Anegative)/(Apositive-Anegative)
3.3.8 Cell migration. HCAECs (2.5*10 5 cells/well) were seeded in 12-well cell culture
plate (BD Biosciences, USA). A straight line in cell monolayer was created by scratching the
surface with a p200 pipette tip (Thermo Scientific, USA). Debris was removed by gently
washing for 3 times with DPBS and cells were incubated with 3 ml ECM supplemented with
different ion solutions. At 0, 6, and 24 hours, optical images were taken by Phase Contrast
Microscope (Advanced Microscopy, USA). The width of the line at upper, middle and bottom
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positions was measured in Image-Pro Plus 6.0 (Media Cybernetics, USA). Recovery rate (RR)
and recovery speed (RS) were calculated by following equations (n=18):
⑥ RR = (Initial Gap Width – Current gap width)/Initial Gap width
⑦ RS = RR/Time
3.3.9 Cytoskeleton staining. HCAECs (2.5*10 5 cells/well) were seeded in 12-well cell
culture plate and treated with ECM supplemented with different MgCl2 for 24 hours. Image-iT
Fix-Perm kit (Invitrogen, USA) was used to fix cells. Microfilament/F-actin was stained by
Actin Green 488 Ready Probes Reagent (Invitrogen, USA). Microtubule was stained by mouse
anti-β tubulin (Invitrogen, USA) followed by Alexa Fluor 546 rabbit anti-mouse IgG (Invitrogen,
USA). Cell nucleus was stained by SlowFade Gold Anti-fade Reagent with DAPI (Invitrogen,
USA). Images were taken by EVOS Inverted Fluorescent Microscope (Advanced Microscopy,
USA). Fluorescent intensity of the cells was extracted by using ImageJ 1.49 software (NIH,
USA). Contrast of the representative images was auto-adjusted by Image-Pro Plus 6.0.
3.3.10 Gene expression. HCAECs (107 cells/dish) were seeded in 100 mm culture dishes
(BD Technologies, USA) and allowed to attach for 24 h. Then the cells were treated with either
ECM, ECM supplemented with 10 mM MgCl2, or ECM supplemented with 50 mM MgCl2,
respectively for 24 h. Cells were harvested and total RNA was extracted by using RNeasy Mini
Kit (Qiagen, USA) and subsequently quantified by a spectrophotometer (Nanodrop 2000, USA)
with OD260/OD280 ratios between 1.9 and 2.1. Total of 600 ng RNA was used for reverse
transcription by a RT 2 First Strand Kit (Qiagen, USA). Reverse-transcription was performed in a
thermo cycler (T100, Bio-Rad, USA). Then 91 µl RNase-free water was added to the 20 µl
cDNA mix and stored at -20℃ Freezer (Puffer Bubbard, Thermo Scientific, USA). HCAECs
gene expression analysis was performed in CFX96 Touch RT-PCR Detection System (Bio-Rad,
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USA) by using RT2 Profiler PCR array (Qiagen, USA) for endothelial cell (EC). The array
includes 84 functional genes, 5 housekeeping genes, 3 reverse-transcription controls (RTC), and
3 positive PCR controls (PPC). 25 µl PCR components mix including cDNA, SYBR Green
Mastermix and RNase-free water was dispensed to the RT2 Profiler PCR Array plate. After
initial heat activation (95℃，10 min), cDNA was amplified as the following parameters: 95°C
for 15 s and 60°C for 1 min. After the amplification, melting curve analysis was performed using
the default melting curve program. Only the genes with one single melting peak were chose for
final analysis. Data was analyzed by Bio-Rad CFX Manager 3.1 (Biorad, USA). 2-ΔΔCt method
was used to calculate gene fold changes [92].
3.4 Collagen Self-assembly on Mg
3.4.1 Concentration. Rat tail type I collagen solution (Life Technologies, USA) of 3
mg/ml was diluted by D-phosphate-buffered solution (DPBS, Invitrogen, USA) to 10, 50, 100,
and 200 µg/ml. 50 µl final collagen solutions (pH of 7) were spread on testing materials surface
(polished up to 1200 grit SiC paper) followed by incubating under 37°C for 2 hours and then
dehydrate with ethanol gradient. The morphology of final collagen structure was characterized
by Scanning Electron Microscope (SEM, SU8000, Hitachi, USA).
3.4.2 pH. The pH of DPBS (7.49) solutions were adjusted to 7, 9, and 11 by 1 M NaOH
(Sigma-Aldrich, USA) and 1 M HCl (Sigma-Aldrich, USA). Stock collagen solution was diluted
by DPBS solutions with different pH to final concentration of 200 µg/ml. 50 µl final collagen
solutions were spread on Mg and AZ31 surface (polished up to 1200 grit SiC paper) for 2 hours
of assembly, then followed by dehydration using ethanol gradient. The morphology of collagen
was imaged by SEM.
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3.4.3 Assembly time. DPBS diluted collagen solution (50µl of 200µg/ml , pH of 7) was
spread on Mg and AZ31 surface (polished up to 1200 grit SiC paper) and allowed to assemble
for 4 h and 8 h. Then samples were dehydrated with ethanol gradient. The morphology of
collagen was imaged by SEM.
3.4.4 Surface roughness. Mg and AZ31 were divided into 3 groups and polished up to
180, 800 and 1,200 grit SiC paper. Materials polished up to 180 grit SiC paper were denoted as
rough surface (RS); materials polished up to 800 grit SiC paper were denoted as semi-rough
surface (SR); and materials polished up to 1,200 grit SiC paper were denoted as smooth surface
(SS). Surface roughness was characterized by WYKO Optical Profiler (Veeco, USA). 50µl
200µg/ml DPBS diluted collagen solution (pH of 7) was spread on Mg and AZ31 surface and
allowed to assemble for 2 h. The morphology of collagen fibril was imaged by SEM.
3.4.5 Collagen dynamic adsorption. RS, SR and SS materials were soaked into 1 ml 60
µg/ml diluted collagen solution (pH of 7) with only one side exposed to the solution. The amount
of absorbed collagen was quantified by Sirius Red Assay (Abacam, USA) according the method
described previously with minor modification [93,94]. In brief, materials were soaked into
collagen solution for 0.5h, 1h, 2h, 4h, and 8h, respectively. At each time point, samples were
removed and washed with DPBS for 3 times. Then the unattached collagen in solution was
transferred to a new tube followed by incubation with Sirius Red for 1 hour. The solutions were
centrifuged at 8,000 g for 15 min and the dye was eluted by 0.1 M NaOH. The absorbance was
measured at 540 nm by 10S UV-Vis Spectrometer (Thermo, USA). Standard curve of a series of
collagen solution (7.5, 15, 22.5, 30, 37.5, 45, 52.5, and 60 µg/ml) was obtained as the same
procedures. Linear regression was performed in Prism 5 (GraphPad, USA). The attached
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collagen was calculated by subtraction of initial collagen by the collagen remained in the
solution.
3.4.6 Cell attachment. Mouse osteoblasts (MC 3T3, ATCC, USA) were expanded in
Minimum Essential Medium α (MEM, Life Technologies, USA) supplemented with 10 % fetal
bovine serum (Sciencell, USA), 100 U/ml penicillin (Sciencell, USA) and 100 µg/ml
streptomycin (Sciencell, USA) in humidified incubator (Heracell 150 I, Thermo, USA) with 5 %
CO2 as previously described [95]. Collagen solution (50 µl 200 µg/ml , pH of 7) was allowed to
self-assemble on Mg and AZ31 with RS, SR, and SS for 2 h in a 24-well culture plate (BD
Bioscience, USA). Then these materials were gently rinsed by DPBS for 3 times. 50 µl cell
solution with density of 10,000 cell/ml was dipped onto the surface of collagen treated materials.
Cells were allowed to attach for 30 min and then samples were washed gently with DPBS for 3
times. After 4 hours, cells were fixed with 4 % paraformaldehyde (Boston Bioproducts, USA)
followed by ethanol gradient dehydration for 10 minutes. Samples were coated with gold
nanoparticles for 2 min, and imaged by SEM.
3.4.7 Cell proliferation. Mg and AZ31 with different surface roughness treated by
collagen as described above were used to test cell proliferation. MC 3T3 Cells were seeded onto
the collagen coated material surface with density of 10,000 cell/ml in a 24-well culture plate. At
1st, 4th, and 7th day, cell culture media were changed and cells were stained by Live/Dead kit
(Invitrogen, USA). Culture media were centrifuged (Biofuge Stratos, Thermo, USA) at 8,000 g
for 10 min and pH was measured by a pH meter (Eutech, USA). The fluorescent images were
taken by a digital inverted light microscope (EVOS, Advanced Microscopy, USA).
3.4.8 Mg2+ concentration. Mg2+ concentration was measured by xylidyl blue magnesium
kit (Pointe Scientific, USA) as previously described [96]. In brief, 10 µl aliquot of test solution
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was added to 1.5 ml final xylidyl solution (0.1 mM xylidyl blue, 0.13 mM EGTA, 1.4 M DMSO,
0.02 % potassium cyanide) and incubated for 10 min at room temperature. The absorbance of the
mixtures was measured at 520 nm by a UV-Vis Spectrometer (Thermo, USA). Standard curve
was obtained by using gradient MgCl2 solution. Linear regression was performed in Prism 5
(GraphPad, USA). Mg2+ concentration was determined by the standard curve.
3.5 Mg Coating
3.5.1 Fluoride Coating. The prepared Mg samples were immersed horizontally in 1.0 ml
of 47-51 % hydrofluoric acid (Sigma-Aldrich, US) for 3 days. At day 3, the alloys were removed
from hydrofluoric acid (HF) and allowed to air dry. The SU8000 SEM (Hitachi, US) was used to
measure the surface morphologies of the alloys, and the Quantax EDS for SEM (Bruker, US)
was used to measure the alloys’ thicknesses.
3.5.2 Collagen coating. Rat tail type I collagen (3 mg/ml) was obtained from life
technologies, US. The stock collagen solution was diluted with DPBS (Invitrogen, US) to the
final concentration of 200 μg/ml, and then placed onto the prepared material surfaces. Following
surface coating, the alloys were incubated in a humidified incubator (Heracell 150 I, Thermo,
US) at 37.0 ºC with 5.0 % CO2 for two hours. After two hours, samples were washed with
DPBS for 3 times to remove unattached collagen followed by gradient ethanol dehydration. All
the materials were stored at 4 ºC.
3.5.3. In vitro endothelialization. A total of 50 μl endothelial cell (50,000 cells/mL) with
serum free culture medium were pipetted onto the surface of each sample in a 24-well tissue
culture plate (BD Biosciences, US). Thereafter, the cells were allowed to attach for fifteen
minutes. Then all the materials were gently washed with DPBS for 3 times to remove the
unattached cells. Thereafter, each alloy was immersed in 2.0 ml serum free culture medium, and
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the HCAECs were incubated in a humidified environment at 37.0 ºC, 5.0 % CO2. LIVE/DEAD
Viability Kit (Invitrogen, US) was used to test cell attachment and viability at 1, 2, and 3 days,
respectively. Culture medium was changed every 24 hours. Culture medium was removed from
the wells, and the materials were incubated for 30 minutes with 1.0 ml DPBS containing 20 μM
Ethidium Homodimer-1 and 5 μM Calcein AM. Following incubation, cells were imaged under
digital inverted light microscope (EVOS, Advanced Microscopy, US).
3.6 Statistical Analysis
All data was expressed as Mean±SD. Statistical analysis was performed in Prism 5
software (GraphPad, US). For analysis of ion dose effects, nonlinear fit for dose-responseinhibition in Prisma was used. Unpaired student’s t-test was performed to compare the
significance level of treatment group with control group. One-way ANOVA was used to test
significant difference in hemolysis and cell viability. Multiple comparisons within one group
were performed by using one-way ANOVA followed by post hoc analysis. It is considered
significantly different statistically if the P < 0.05.
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CHAPTER 4
Results
4.1 Endothelial Responses Exposed to Metal Ions.
4.1.1 EC viability. ECs were treated with different ion solutions for 24 hours and the
relative MTT viability results are shown in Figure 2. The dashed lines indicate the half maximal
effective concentration (EC50). Stars indicate that the cell viability was significantly decreased
compared to control (n=3, P<0.05).

Figure 2. MTT viability of ECs as a function of salt concentration.
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The overall cell viability decreased as ion concentrations increased except for the group
treated with CaCl2. For the group of NaCl treatment, viability was not affected up to 100 mM
and then decreased to 80.03±0.2% at 200 mM (Figure 2F).With the increase of Mg ion
concentration from 8 mM to 103 mM, viability decreased from 105% to almost 0. Nonlinear fit
(R2=0.97) for dose-response-inhibition showed that viability was not significantly affected when
the Mg2+ is less than 30 mM. The half maximal effective concentrations (EC50) for MgCl2,
ZnCl2, and AlCl3 were about 66.7 mM, 130 µM and 2,400 µM, respectively. The EC50 for the
four REs ranges from 710 to 990 µm. When the CaCl2 concentration was higher than ~60 mM, it
could interfere with the MTT result (Figure 2C).

Figure 3. LDH release from ECs as a function of salt concentration.
4.1.2 Lactate dehydrogenase (LDH) release. The relative amount of LDH released into
cell culture media after endothelial cells treated with MgCl2, CaCl2, ZnCl2 AlCl3 and REs was
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shown in Figure 3. Stars indicate that the LDH release was significantly increased compared to
control (n=3, P<0.05). As the concentration of MgCl2 increased from 10 mM to 70 mM, the
relative quantity of released LDH increased from 0.6±0.4% to 112.4±5.6%, and then started to
drop. The highest LDH release in CaCl2 treated group was at concentration of 60 mM. In the
ZnCl2 treated group, LDH release showed the same tendency and the turning point was around
40 µM of ZnCl2. LDH release decreased first when concentrations of AlCl3 increased from 100
to 1,800 µM, then it increased again and peaked at 2,000 µM AlCl3 and then started to drop
(Figure 3D). In the REs treated groups, the overall LDH release increased with increasing ion
concentrations (Figure 3E and Figure 3F).

Figure 4. ECs proliferation rate as a function of salt concentration.
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4.1.3 EC proliferation rate. The overall HCAECs proliferation rate decreased as the
concentrations of MgCl2 and CaCl2 increased (Figure 4). One interesting observation was that
MgCl2 at 10 mM improved the proliferation rate to 114±0.70%, significantly higher than control
group, while the proliferation rate of 10 mM CaCl2 treated group was 90.5±14.9% which is not
significantly different from the control. The proliferation rate of cells treated with 10 µM ZnCl2
increased to 110.8±12.5%, and then decreased slowly as the increase of ZnCl2 to 40 µM (Figure
4B). For AlCl3, cell proliferation was significantly decreased at 1,000 µM. REs had much severe
adverse effects on the cell proliferation compared with AlCl3. DyCl3 and GdCl3 significantly
decreased the proliferation rate at 100 µM. In all REs treated HCAECs, cell proliferation
declined gently with concentrations increase from 100 to 500 µM, and then decreased sharply
from 500 to 1,000 µM.
4.1.4 EC migration. Figure 5 shows the EC migration test. ECs were treated with
endothelial cell culture media supplemented with different concentration of magnesium chloride.
The gap width (GW) of the line was calculated by Image Pro software. Recovery rate (RR) and
recovery speed (RS) are shown on the top left corner of the image. For the control group, the
recovery ratio (RR) was 39±4% after 6 h and the wound completely healed after 24 h. For the
group supplemented with 10 mM and 20 mM MgCl2, the simulated wound also completely
healed after 24 h. The RSs and RRs were even significantly higher than that of control group
during the first 6 h (n=18, P<0.05). In the 30 mM and 40 mM groups, RR and RS were
comparable to the control group at 6 h while significantly decreased at 24 h. In the 50 mM group,
not only the RR and RS significantly decreased at 6 h, but also a large amount of cells peeled off
along the edge of the wound.

32

Figure 5. Optical images of ECs migration under the effect of MgCl2.
4.1.5 Cytoskeleton staining. Cytoskeleton proteins, actin (Green) and microtubule (Red)
structures were shown in Figure 6.
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Figure 6. Cytoskeleton staining images of ECs treated by ECM supplemented with MgCl2.
Cell morphology and microtubule structure were not significantly affected as the increase
of MgCl2 concentration. Some small green fluorescent dots were visible in all groups. Ventral
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stress fibers which are actomyosin bundles connected to focal adhesions at both ends [97], were
observed in all groups. At 10 mM and 20 mM MgCl2, increased amount of thicker ventral stress
fibers and nebulous fluorescence were displayed. Stress fibers were arranged along the edges of
each cell and microtubule network was surrounded by the actin stress fibers in the 30 mM group.
There were some discontinuities within the intercellular cell-to-cell junctions as the MgCl2
concentration increased to 40 mM. The discontinuous areas got larger when MgCl2 increased to
50 mM. A few ventral stress fibers were visible and cells were fraught with nebulous green
fluorescence at 50 mM group.
Normalized actin fluorescent intensity per cell (Figure 7) showed that total cellular actin
significantly increased when supplement MgCl2 concentration was within 10 to 40 mM whereas
actin quantity was not significantly different from that of control group when MgCl2 increased to
50 mM (n=12, P<0.05).

Figure 7. Normalized green fluorescence intensity (GFI) of ECs actin microfilament. Stars
indicate GFI significantly different from control.
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4.1.6 EC gene expression. We used a gene array for endothelial cells to examine the
gene expression profile under the influence of Mg ion. Gene functions are classified into 7
different groups (Vaso C&D represents vasoconstriction & vasodilation). X-axis represents
different gene functions and Y-axis represents the number of genes significantly changed. The
bars above the X-axis are the up-regulated genes and below are the down-regulated genes. (n=3,
P<0.05) We used a gene array for endothelial cells to examine the gene expression profile under
the influence of Mg ion.

Figure 8. ECs gene expression after treated by ECM supplemented with 10 mM MgCl2 (A) and
50 mM MgCl2 (B).
In the 10 mM MgCl2 group, 12 genes were excluded due to the absence of distinctive
melting peak. Among the total of 72 detectable genes, 26 were up-regulated and 7 were downregulated (Figure 8A). The remaining 39 did not show significant change. Table 9 summarizes
some significantly changed genes under 10 mM of MgCl2 (n=3, P<0.01). The expression fold
change of FGF1, FLT1, FN1, MMP1, NOS3, and PROCR was more than 2 times that of the
control. The majority of genes affected were related to angiogenesis and cell adhesion signaling
pathways. As for the 50 mM MgCl2 group (Figure 8E), 31 genes were up-regulated and 9 genes
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were down-regulated. 15 of the up-regulated genes are involved in the angiogenesis signaling
pathway and 12 up-regulated genes are related to cell adhesion signaling pathway.
Table 9
Gene expression changes of HCAECs (ECM supplemented with 10 mM MgCl2 with normal ECM
as control)

Gene
ACE
FGF1
FLT1
FN1

Function

Angiogenesis
Angiogenesis, Cell adhesion
Angiogenesis
Angiogenesis, Inflammatory response, Cell adhesion,
Coagulation, Platelet activation
HMOX1
Angiogenesis, Vaso-C&D, Inflammatory response, Apoptosis
IL6
Angiogenesis, Vaso-C&D, Inflammatory response, Apoptosis
IL7
Apoptosis,
ITGAV
Cell adhesion
MMP1
Coagulation
NOS3
Angiogenesis, Vaso-C&D, Platelet Activation
PGF
Angiogenesis
PROCR
Coagulation
TIMP1
Coagulation, Platelet activation
VEGFA
Angiogenesis, Cell adhesion, Platelet activation
*(Percentage of control, P<0.01)

Average
fold
change*
1.978
2.415
2.124
2.383
1.799
0.624
0.518
1.762
2.087
3.429
1.337
2.264
1.779
1.360

In Table 10, AGTR1, ANXA5, CCL2, CCL5, FGF1, FN1, ITGAV, PLAT, and VCAM1
were up-regulated more than 2-fold higher than that of the control. IL7, PF4, PTGIS, SELE, and
SELL were down-regulated to less than 0.5-fold of control. Among them, FLT1, NOS3, MMP1
and PROCR were the most significantly affected genes (fold change > 2, P<0.01) at 10 mM
MgCl2 but interestingly, they did not show significant changes at 50 mM. FGF1 and FN1 were
up-regulated at both concentrations.

37
Table 10
Gene expression changes of HCAECs (ECM supplemented with 50 mM MgCl2 with normal ECM
as control)

Gene

Function

AGTR1
ANXA5
CCL2
CCL5
FGF1
FN1

Angiogenesis
Apoptosis, Coagulation
Angiogenesis
Angiogenesis, Inflammatory response, Apoptosis
Angiogenesis, Cell adhesion
Angiogenesis, Cell adhesion, Inflammatory response,
Coagulation, Platelet activation
IL7
Apoptosis
ITGAV
Cell adhesion
PF4
Apoptosis, Coagulation, Platelet activation
PLAT
Coagulation
PTGIS
Vaso-C&D
SELE
Inflammatory response, Cell adhesion
SELL
Cell adhesion, Coagulation
TIMP1
Coagulation, Platelet activation
VCAM1
Inflammatory response, Cell adhesion
*(Percentage of control, P<0.01)

Average
fold
change*
3.014
2.356
4.290
8.413
3.486
2.300
0.403
2.736
0.453
5.140
0.424
0.277
0.393
1.439
3.436

4.2 Biocompatibility of Mg-RE Alloys.
4.2.1 Electrochemical corrosion properties. Potentiodynamic polarization curves of
four RE alloys and pure Mg in HBS are shown in Figure 9A. An obvious shift of Ecorr in
cathodic direction and reduction in cathodic current density were observed in R3 and R4. The
current density in all alloys decreased significantly compared with pure Mg. The Ecorr, Icorr and
corrosion rate of all Mg materials were summarized in Figure 9B. The corrosion rates of three
RE alloys were 3 to 10 times lower than that of pure Mg.
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Figure 9. Potentiodynamic polarization curves of Pure Mg and Mg-RE alloys in HBS (A).
Electrochemical corrosion data of Pure Mg and Mg alloys (B).
4.2.2 Hemolysis rate. The hemolysis rates (HR) of the materials are shown in Figure 10.
All the hemolysis rates of the materials were smaller than 0.6 %, much lower than the 5 %
threshold, therefore, all samples were considered non-hemolytic according to the ISO 109934:2002 standard [98,99]. There was no significant difference among all the Mg materials tested.

Figure 10. Hemolysis rate of diluted whole human blood incubated with Mg materials for 1 h.
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Figure 11. Representative SEM images of platelet adhesion and activation on Mg materials: (A)
pure Mg, and (B-E) R1-R4.
4.2.3 Platelet adhesion. Figure 11 shows the platelet adhesion and activation after
incubation on the material surfaces for 1 hour. Activated platelets with spreading dendriticals
connecting with their proximal platelets were observed on the pure Mg surface. In addition, a
few platelets with long dentritical structure were seen under higher magnification. R1 and R2
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had similar density of adherent platelets but with less spreading dendriticals compared to pure
Mg. On the other hand, the number of adherent platelets on R3 and R4 was significant less than
that on pure Mg (Figure 12).

Figure 12. The number of adherent platelets. Star indicates that the platelet number is
significantly different from that of pure Mg group (P < 0.05).

Figure 13. HAECs viability by MTT after treated with different Mg material extracts for 2 days
(A), 4 days (B), and 7 days (C).
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4.2.4 Indirect EC viability. MTT cell viability on days 2, 4 and 7 with different
concentrations of alloy extract solutions is shown in Figure 13. Stars indicate that the cell
viability is significantly different from that of pure Mg group (P<0.05).The overall cell viability
for all groups decreased as the concentrations of the extract solutions increased. Extract solution
of R3 and R4 didn’t affect cell viability at any concentrations compared with pure Mg. On the
2nd day, reduced cell viability was observed in R1 and R2. On day 4, there was no significant
difference among all the materials and pure Mg control except for R1 and R2 at 75 %
concentration. On day 7, cell viability of all alloys was not significantly different from pure Mg
control. Representative optical images of HAECs on day 7 were shown in Figure 14. Red arrows
indicate the cell debris and dead cells. Cells all looked healthy, and there were no obvious
morphological changes for all groups at 10 % and 25 % extract solutions. There were some dead
cells and debris floated around when the extract concentration reached 50 %. In 75 % group, the
cell density decreased significantly, especially for the pure Mg.

Figure 14. Representative optical images of HAECs morphology after treated with Mg material
extracts for 7 days.
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Figure 15. Representative fluorescent images of ECs on Mg materials after 3 h: (A) Pure Mg,
(B) Tissue culture plate, and (C-F) R1-R4.
4.2.5 Direct Endothelialization. The attached HAECs were detected by fluorescent
staining with green for live cells and red for the dead. The density of attached cells after 3 hours
on R1 and R2 were lower than that on pure Mg, tissue culture plate, R3 and R4 (Figure 15).
Most of the cells attached on the sample surface in all tested materials were still in round shape.
Some dead cells could be observed on pure Mg, R1, and R2. In comparison, a few completely
spread cells in healthy shape were seen on tissue culture plate, R3 and R4.
After 24 hours, most cells on pure Mg were dead, and many air bubbles with diameter of
~50 µm evolved on the surface of all the materials (Figure 16). More cells survived on R1 and
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R2 compared to pure Mg but were in a stressed condition. On R3 and R4, majority of the
attached cells were still viable, and they looked healthy and well attached, spreading in a spindle
shape. However, cell density on R3 and R4 significantly decreased compared to that on the tissue
culture plate control.

Figure 16. Representative fluorescent images of ECs on Mg materials after 24 h: (A) Pure Mg,
(B) Tissue culture plate, and (C-F) R1-R4.
4.3 Collagen Self-assembly on Mg and Subsequent Cell Attachment.
4.3.1 Effect of collagen concentration. Collagen self-assembly with different
concentrations of collagen monomers on SS Mg and SS AZ31 at neutral pH was examined first
(Figure 17).
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Figure 17. Representative SEM images of collagen self-assembly on Mg and AZ31.
The concentration of collagen monomer is marked on the upper left corner of each
images. On pure Mg, collagen monomers agglomerated into a non-uniform structure and no long
fibril was observed when the concentration was lower than 50 µg/ml. Some spherical particles
were present on the surface of pure Mg in both 10 µg/ml and 50 µg/ml groups. When the
collagen concentration reached to 100 µg/ml, a few fibrils started to appear. The structure
changed from thin fibrils to wide bands as the initial concentration increased to 200 µg/ml. On
AZ31 surface, long fibril started to appear as the collagen concentration reached to 50 µg/ml. In
addition, sparsely dispersed woven structure composed of collagen fibers (fibril bundles) were
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observed in the 100 µg/ml group. Multiple-layer network structure with collagen ribbon of 100
nm width was the predominant structure in the 200 µg/ml group. Spherical particles in different
sizes were present in all the groups.

Figure 18. Representative SEM images of 200 µg/ml collagen self-assembly in DPBS with
different pH values.
4.3.2 Effect of pH. Effect of pH on collagen assembly was also investigated. SEM
images of collagen self-assembly under different pH on SS materials for 2 hours are shown in
Figure 18. At pH 7, collagen ribbons with width ~100 nm conjugated with other fibrils, forming
a multiple layer network structure on pure Mg. A few nanofibril side chains connecting adjacent
long collagen ribbon were also seen. On AZ31, some parallel collagen ribbons were connected
with adjacent collagen ribbons by smaller branches and others merged with their proximal
collagen, forming a uniform sheet. At pH 9, more collagen ribbons wove together spreading on
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Mg surface. In addition, some bare areas and crevices were observable. The whole surface of
AZ31 was almost covered by a collagen layer with some small holes. Few long collagen fibrils
were present on pure Mg when pH rose to 11. On AZ31, thin fibrils randomly crossed with
others, resulting in a network structure. A lot of nano-spherical particles attached to the collagen
fibrils.

Figure 19. Representative SEM images of 200 µg/ml collagen self-assembly on Mg and AZ31
for 4 h and 8 h.
4.3.3 Effect of reaction time. Figure 19 shows the structures of collagen assembling for
different time periods on SS materials at neutral pH. The concentration of collagen solution is
200 mg/ml. Arrows in black color indicates the large fiber bands. After 4 hours assembling, a
cancellous underneath layer was covered by some long collagen ribbons on pure Mg. Similar
cancellous structure was found on AZ31, but less thin collagen fibrils could be observed on the
top. When the assembly time reached 8 hours, micrometer-wide fibers were present on both pure
Mg and AZ31. On pure Mg, a lot of small lamellar sheets were observed between two thick
fibers.
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Figure 20. 3-D surface topography of Mg sample polished by different SiC paper (A: 180 grit;
B: 800 grit; C: 1200 grit).
4.3.4 Effect of surface roughness. Representative 3-D topographical images of materials
after polished by different SiC paper are shown in Figure 20. The average roughness (Ra) and the
corresponding root mean squared roughness (Rq) were also calculated (Figure 20). Figure 21
shows the collagen self-assembly on the samples with different surface roughness. On the RS
Mg materials, long collagen fibers interwove with each other resulting in a compact woven layer
with a few fish-like scales on the top. The woven layer on RS AZ31 was less dense compared
with that on RS Mg. Larger and more fish-like scales structures could be seen on the RS AZ31.
For both AZ31 and pure Mg with SR, collagen fibers aligned parallelly to each other at some
places while randomly intertwined at other places. On SS of both materials, collagen bands were
similar as described previously (Figure 17).
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Figure 21. Representative SEM images of 200 mg/ml collagen self-assembly on Mg (A, C, E)
and AZ31 (B, D, F) with different surface roughness (A–B: RS; C–D: SR; E–F: SS).
4.3.5 Collagen assembly quantification. We also quantified the amount of collagen on
the material surface during its assembly. A standard curve for quantification of collagen content
was established (Figure 22A). The optical absorbance at 540 nm versus collagen content
displayed reasonable linearity within the range from 5 to 60 µg/ml. Collagen dynamic adsorption
curves on Mg and AZ31 surfaces are shown in Figure 22B and Figure 22C. For both AZ31 and
pure Mg, less collagen was able to be absorbed onto the SS materials at the initial phase (0.5 h)
compared with RS and SR materials. The amount of attached collagen increased as the
adsorption time increased and reached equilibrium state after 4 h for all three groups of AZ31.
Collagen on the pure Mg with SS kept increasing slowly from 0.5 to 2 h. In comparison, collagen
on pure Mg with RS peaked at 2 h and then started to drop. Among all the groups, the highest
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amount of adsorbed collagen was 30.69±1.96 µg on RS Mg at 2 h. Two-way ANOVA analysis
revealed that both time and surface roughness had significant effect on collagen adsorption on
pure Mg.

Figure 22. Collagen adsorption quantification. Standard curve for quantification of collagen (A).
The amount of collagen absorbed on Mg (B) and AZ31 (C) with different surface roughness.

Figure 23. Representative SEM images of MC 3T3 cell attachment on collagen self-assembled at
Mg and AZ31 with different surface roughness.
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4.3.6 Bone cell attachment and proliferation. After Mg and AZ31 with different
surface roughness were treated by 200 µg/ml collagen solution for 2 h, the materials were used to
test subsequent bone cell attachment (Figure 23). SEM images showed that both round cells and
cells with filopodia were observed on RS AZ31 and pure RS Mg. On SR materials, most cells
were well attached with flattened morphology and a few fibroblast-like cells with webbing could
also be seen. In addition, super long filopodia from some cells span over a large distance and
reached the edge of other cells or an empty area. On the SS materials, most cells were well
flattened with very large cell surface area. Cell density on SR and SS was significantly higher
than that on RS.

Figure 24. Representative fluorescent images of MC 3T3 cells growing on collagen selfassembled at AZ31 with different surface roughness for 1, 4 and 7 d.
Fluorescent live/dead cell analysis was then performed to examine the bone cell
proliferation. MC 3T3 cells on AZ31 and Mg treated with 200 µg/ml collagen solution for 2 h
are shown in Figure 24 and Figure 25, respectively.
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Figure 25. Representative fluorescent image of MC 3T3 cells growing on collagen selfassembled at Mg with different surface roughness for 1, 4 and 7 d.
Cells displayed healthy morphology in all the groups after one day. Cell densities on SR
and SS AZ31 were significantly higher than that on RS AZ31 (Figure 24). Some dead cells were
visible after first day on RS AZ31. Small gas bubbles were present in all the materials. After
three days’ incubation, cell density on all the AZ31 materials increased. On the RS AZ31, cells
elongated at the same direction. After seven days, cell density further increased and multiple
layers of cells could be seen in all the three groups. Most of the cells on the RS group still
aligned in the same direction. Larger gas bubbles emerged in all groups. On pure Mg, cell
densities significantly decreased at 4th and 7 th day. At the first day, cells showed similar uniform
elongation on the RS pure Mg. However, normal spreading cells could barely be observed on the
SS Mg at 4th and 7th day.
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Table 11
pH value of the cell culture media after incubated with cells on materials

Material
RS
AZ31 SR
SS
RS
SR
Mg
SS

1 day
7.93±0.05
7.70±0.08
7.75±0.08
8.30±0.14
8.01±0.06
8.13±0.06

pH
4 day
7.88±0.03
7.92±0.03
7.91±0.06
7.95±0.03
7.92±0.03
7.95±0.03

7 day
7.94±0.03
7.85±0.05
7.76±0.07
7.96±0.03
7.92±0.03
7.87±0.03

Table 11 summarizes the pH value of cell culture media during the culture. In both AZ31
and Mg groups, the materials with RS showed significantly higher pH change than the materials
with SR and SS after the first day. Mg2+ concentration (Figure 26) after collagen was incubated
with Mg and AZ31 of different surface roughness for 2 h was all around 25 mM (Error bars were
omitted for clarity purpose). In contrast, Mg2+ concentration in the cell culture media was
significantly lower than that in the collagen solution for the AZ31 group from 1 day to 7 day.

Figure 26. Mg2+ concentration after the materials (A-AZ31; B-Mg) were incubated with collagen
solution for 2 h and cocultured with cells for 1, 4 and 7 days.
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4.4 Endothelialization of Mg-RE Alloys with Fluoride and Collagen Coating.
4.4.1 Surface morphology of HF conversion coating. Surface morphology of the three
materials after treated with HF for 3 days was shown in Figure 27. Pure Mg surface was
converted into a layer of granular and columnar structure. The diameter of the granules was ~50
nm and the length of the columnar structure was ~200 nm. In both R1 and R2, the granular
structures from the converted layers were much smaller than that on the pure Mg surface.
Compared to pure Mg, grain size refinement by rare earth elements or direct reactions between
rare earth elements with HF may cause such finer porous structures on HF treated Mg-RE alloys.
The addition of Zn in R2 could be the reason for the different alignment of the granular structure.

Figure 27. SEM images of fluoride coating morphologies.
The coating thickness in all samples was about 20 µm (Figure 28). The first row is the
SEM images displaying cross sections of Mg fluoride coating in epoxide resin. The images at the
second row and third row are EDS mapping (Mg in green color, fluorine in red color).
Transection images of SEM showed that there was a distinctive boundary between Mg substrate
and the MgF2 modified layer.
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Figure 28. EDS Mapping for cross section of fluoride coating. (Scale bar: 10.0 µm).
4.4.2 Endothelialization on coated Mg material. Live/Dead kit including calcein AM
and Ethidium homodimer-1 (EthD-1) was used to test how cells directly interact with alloys and
coatings. Calcein AM could be metabolized by ubiquitous intracellular esterase activities
resulting in presence of green fluorescence in live cells. EthD-1 is excluded by the intact plasma
membrane of live cells. Upon binding to nucleic acids, the emission intensity of EthD-1 at 635
nm undergoes a 40-time enhancement. Representative images of direct endothelialization for 1, 2,
and 3 days on bare Mg, Mg coated with collagen and Mg treated with HF are shown in
Figure 29. HF treated Mg yielded most attached and viable cells (green) in all groups.
Cell density slightly decreased from 1 st day to 3 rd day on pure Mg treated with HF. For the nontreated pure Mg control group, some dead cells (red) were still observed on the very first day but
none were observed either on day 2 or 3. A few live cells appeared on the surface of collagen
coated Mg but the density was much lower than that on Mg treated with HF. In addition, on days
2 and 3 only, dead cells could be seen on collagen coated group. Collagen coating was used as
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positive control in this study since it is the most abundant extracellular matrix protein which
provides adhesion points for cell attachment and migration.

Figure 29. Endothelial cells cultured on bare Mg, collagen coated Mg and HF treated Mg from
day 1 to day 3. (Scale bar: 10.0 µm).

Figure 30. Endothelial cells cultured on bare R1, collagen coated R1 and HF treated R1 alloys
from day 1 to day 3. (Scale bar: 10.0 µm).
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Figure 30 shows the representative images of direct endothelialization on bare R1, R1
coated with collagen and R1 treated with HF. Results were similar to that of pure Mg group.
Fluoride treated R1 had most viable cells while bare R1 had the least. Better cell attachment was
shown in HF treated R1 group on the 1st day compared to the same one in pure Mg group. Also,
cell density on the 3rd day in HF treated R1 group didn’t decrease.

Figure 31. Endothelial cells cultured on bare R2, collagen coated R2 and HF treated R2 alloys
from day 1 to day 3. (Scale bar: 10.0 µm).
Cell attachment and proliferation on R2 group (Figure 31) were very similar to that in the
R1 group. The most different one was the collagen coated group, and much better
endothelialization was observed compared with R1 and pure Mg groups. Some fully spreading
cells appeared at the very first day which demonstrated that collagen could improve the
cytocompatibility to a certain degree. On the second day, most cells were dead and only a few
cells were alive however in a stressed condition.
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CHAPTER 5
Discussion and Future Research
5.1 Discussion
5.1.1 Endothelial responses exposed to metal ions. Endothelial cells form a semipermeable endothelium monolayer which separates the blood components from the underlying
tissues. It plays important role in immune response, coagulation, growth regulation, modulation
of blood flow and production of extracellular matrix [100]. After a stent is deposited into the
blood vessel, the surface of the stent will directly contact endothelial layer. Re-endothelialization
onto the inner layer of the stent is a very important step for vascular reprogram. Late restenosis,
re-narrow of the blood vessels after stent implantation, is a major problem for current stent
materials. The interaction between stent material and endothelial cells, therefore, is of great
importance. Hence, we examined the responses of HCAECs after exposure to ions of different
individual alloying elements.
The majority of the alloying elements will be released from the material during the course
of degradation. However, it is hard to mimic the real in situ concentrations of different ions for
the in vivo scenarios. The concentration of degradation production could be much higher at the
local microenvironment of stent-endothelial interface than that in the blood stream or other
tissues. Previous studies provide some information on the concentration of Mg ion after
degradation of the alloys in vitro. For example, Mg2+ concentration in DMEM incubated with
Mg-Ca alloy for 72 h was ~57.96 mM [101] and Mg2+ concentration in cell culture media after
Mg-Nd-Zn-Zr alloy was co-cultured with human umbilical vein endothelial cells for 7 days was
9.53 mM [102]. Therefore, we used a concentration range of 10-100 mM for Mg ion in our in
vitro tests. Technically, the final Mg2+ concentration is the summation of 3 mM MgSO4 from the
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ECM and additional supplemented MgCl2. Since Mg is the major component of Mg-based alloy,
the tested concentrations for other alloying elements Ca, Zn, Al and REs were much lower.
To rule out the potential interference from the Cl- present in the solution, 10-200 mM
NaCl solution was used and no significant effect on cell viability was observed up to 100 mM
NaCl. Besides the direct effects of ions on cellular activities, pH and osmolality changes in the
solution induced by the ions may also affect cells. We did not observe significant pH changes in
all the final ion solutions used. As for osmolality, similar results were observed except when
MgCl2 concentration was higher than 66.7 mM. 66.7 mM MgCl2 solution has the similar
osmolality as 100 mM NaCl. Therefore, both osmolality stress and Mg2+ ion may play a role in
reduced cell viability when MgCl2 concentration is over 66.7 mM, the EC50 value in our case.
Feyerabend et al. showed that the EC50 of MgCl2 on MG63 cells and human umbilical cord
perivascular cells (HUCPCs) were 53 mM and 73 mM, respectively [48]. The tolerance of
HCAECs (EC50 of 66.7 mM) on MgCl2 is between that of MG63 cells and HUCPCs. The EC50
of ZnCl2 measured here for endothelial cells is ~130 µM, comparable to that of mouse
macrophage cell line (~203.89 µM) [103]. The slight differences between these measurements
are probably because of different types of cells. The pH and Ca2+ may also interfere with MTT
assay. Our test showed that the absorbance of the blank control without cells significantly
increased when the Ca2+ concentration is higher than 60 mM. This false positive result is most
likely caused by the aggregates of sodium dodecyl sulfate in solution with excess Ca2+ [104]. It
is also mentioned by Fisher et al. that highly alkaline environment may induce false-positive
result as well [101]. Hence, MTT test should be applied with caution at the situations where pH
is highly alkaline or the alloy degradation products include Ca2+. The toxicity of REs on cells is
most likely caused by the displacement of Ca2+ ion from functional biomolecules as they have
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the similar radius as Ca2+ ion [105]. It was shown by Drynda et al. that REs under 100 µg/ml
(around 500 µM) didn’t lead to significant metabolic changes of smooth muscle cells [105].
Feyerabend et al. also demonstrated that REs under 1,000 µM didn’t reduce human osteosarcoma
cell line MG63 viability. All REE ions had significant toxic effects on endothelial cell viability
when their concentrations were higher than 400 µM, indicating that endothelial cell is more
sensitive to REs.
The effects of MgCl2, CaCl2, ZnCl2, AlCl3, and REs on HCAECs membrane were studied
by LDH assay, which is also widely used to test the biocompatibility of Mg-based alloys [106108]. LDH, an indispensable cytoplasmic enzyme for all cells, is rapidly released to extracellular
space upon damage of the plasma membrane. Han et al. reported that the decreased LDH level in
cells treated by 20 µg/ml CuSO4 for 24 h is caused by LDH inactivation by Cu2+ [109]. Cells
treated with MgCl2, CaCl2, ZnCl2 and AlCl3 all showed a decreased LDH tendency when the ion
concentration is higher than certain thresholds. This may also be caused by the inactivation of
LDH due to high ion concentration.
In comparison with LDH and MTT tests, BrdU is not dependent on direct enzymatic
reaction so that the interference from Mg corrosion products is negligible. Based on this fact,
some researchers believe that BrdU is a more appropriate test for cytotoxicity of Mg materials
[110]. It was also shown that cell proliferation rate by BrdU assay was more sensitive than MTT
test for some metal ions. For example, cell viability was not significantly affected at 30 mM
MgCl2 (Figure 2A) while the proliferation rate (Figure 4) was significantly reduced to 63±9%.
Moreover, 20 mM CaCl2 demonstrated significant inhibition on cell proliferation rate. This
reduced proliferation is probably caused by ionic imbalance and production of reactive oxygen
species (ROS). Ionic imbalance may lead to altered signaling pathway related to cell cycle,
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reduced enzymes activities and increased DNA replication errors. It is well known that metal
corrosion products can induce ROS production [111,112]. Extra ZnCl2 can induce serious
mitochondrial dysfunction and remarkable intracellular ROS production [112]. Depending on the
level of ROS, it may increase the cell proliferation at low level or cause damages to DNA and
other biomacromolecules, leading to decreased proliferation or even cell apoptosis at high level
[113]. Therefore, higher cell proliferation rate at the low ion concentration was likely caused by
lower amount of ROS induced by metal ions. As the metal ion concentration is increased, the
increasing ROS production caused the dampened proliferation. Also, Mg2+ is a cofactor for DNA
polymerase and other important enzymes participated in DNA replication. Previous study by
Maier et al. showed that 10 mM MgCl2 could stimulate endothelial proliferation [114], consistent
with the BrdU proliferation result (114±0.70%) reported here.
Endothelial cell migration is essential for both angiogenesis and endothelialization. As
the re-endothelialization on the stent progresses, the chance of coagulant molecules or platelets
attaching to the stent reduces. We used scratch wound assay to study how Mg ion affect
endothelial cell migration as it is a simple, inexpensive and very reliable method for cell
migration study [115-117]. Our results show that at 10 mM and 20 mM, MgCl2 increased the
migration of endothelial cells within a few hours. This results is in line with a previous study by
Banai et al. showing that 4 mM Mg2+ can stimulate capillary endothelial cell migration [118].
This might be a very beneficial characteristic for Mg-based stent materials if the degradation
product concentration is maintained within this range. The exact mechanism responsible for this
increased cell migration ability is not fully clear. One of the factors could be the fast assembling
of actin cytoskeleton into stress fiber, filopodia, and lamillipodia [97]. Nitric oxide (NO) as an
important cell migration, vasodilation and angiogenesis regulator may be another factor [119]. In
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the 10 mM MgCl2 treated group, NO synthase III (NOS3) was up-regulated to 3.429 fold of
control. Up-regulated NOS3 may lead to enhanced production of NO and further increase cell
migration ability. In addition, ROS generated by NADPH oxidase may also play an important
role in endothelial cell migration by stimulating some redox signaling pathways [115].
However, higher MgCl2 concentration of 50 mM not only decreased endothelial cell
migration rate but also led to the detachment of a large amount of cells along the edge of the
scratched wound. This could be due to the weakened cell-cell junctions and reduced cell-matrix
adhesion. This interpretation is supported by the fluorescent staining result (Figure 6) where cellcell connection was affected and some discontinuities between the cells could be observed when
MgCl2 was above 40 mM. The changes in junction protein expression could be one of the
reasons. Vascular endothelial cadherin, platelet endothelial cell adhesion molecule (PECAM),
occludin, claudin, and endothelial cell selective adhesion molecule (ESAM) are the major
transmembrane adhesive proteins at endothelial junctions [120]. It was found that CDH5
(cadherin-5, type 2) was up-regulated to 1.56±0.16 fold of control at 10 mM MgCl2 and
1.65±0.05 fold of control at 50 mM (P<0.05), respectively. Occludin and PECAM didn’t show
significant change. Further investigation is needed to explain the detailed changes of cell-to-cell
junctions and cell-matrix adhesion.
Gene expression profile is another important way to study how cells interact with
biomedical materials. It could suggest the subtle cellular regulation changes when metabolic
changes of cells are not detectable. MgCl2 at 10 mM and 50 mM had different effect on HCAEC
gene expression in a concentration dependent manner. The expression fold change of CCL2 and
CCL5 were 4.290 and 8.413 (P<0.01) respectively at 50 mM of MgCl2 indicating strong
inflammatory chemokines regulation [121]. Since Mg2+ is a ubiquitous cofactor for a lot of
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biomacromolecules, it plays a wide range of roles in cell cycle and cell activities. Besides the
direct effect of Mg2+ on enzymes, it is believed that increased Mg2+ could activate
phosphorylation reactions of cell followed by changes of cellular signaling pathways [122]. The
altered genes may have great potential to be used for gene-eluting stent. For instance, if downregulation of a certain gene causes the suppression of one cellular activity, it could compensate
for such a negative effect induced by the biomaterial by delivery of the down-regulated gene
through eluting. One example is the endothelial NOS gene (eNOS), and it was used in geneeluting stent [123]. Results showed that this eNOS-eluting stent demonstrated better reendothelialization and significant reduction in neotintimal formation. Despite that identifying the
effective target genes and successfully deliver to the local tissue could be challenging, this is a
very promising strategy for new type of drug-eluting stents.
Nonetheless, the altered gene expression should not be interpreted as corresponding
functional changes in the same way. More comprehensive studies on gene expression and protein
expression are required to fully illustrate the underlying mechanisms. Mg-alloy degradation
product often is a complex mixture of all the alloying elements. There is no doubt that the effect
of individual elements on endothelial cells is important. The combinative effect of the mixture of
those alloying elements should be further studied in the future as well in order to better
understand how the degradation products affect endothelial cell activity as a whole.
5.1.2 Biocompatibility of Mg-RE alloys. Platelet morphological and biochemical
changes are good indicators for hemocompatibility [124,125]. At the beginning of stent
development, 20 % of self-expandable stents would suffer from subacute stent thrombosis [126].
Platelet activation and adhesion are the important initial steps of restenosis [127,128]. Individual
platelets can be categorized as round, dendritic, spread-dendritic and fully spread corresponding
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to different stages of activation. Static platelet adhesion test is the most convenient and accurate
way to get information about whether the stent material will cause severe platelet adhesion in
vivo. Because extracellular Mg ions can reduce the intracellular calcium ions, Mg alloys could
inhibit platelet adhesion and aggregation [129]. We showed that the density of attached platelets
on pure magnesium was the highest, and the morphology of the adherent platelets on all
materials was almost the same, demonstrating that addition of RE elements into Mg alloys didn’t
trigger the platelet activation. It is still unclear how platelet activation was initiated. We
speculate that the unspecific absorption of von Willebrand factor (vWF) and other plasma
protein caused the initiation of platelet adhesion. Circulating platelets can bind to vWF through
their GPIb-V-IX receptor and lead to the activation cascade [130].
Hemolysis rate was not affected by adding RE elements, indicating the release rate of
those RE elements was very slow and didn’t reach the threshold causing severe red blood cell
lysis. In fact, the hemolysis rate of R1 and R2 was even lower than that of pure Mg. The
hemolysis effect was most likely caused by the degradation of Mg, and subsequent increased
osmosis pressure and elevated pH level.
Re-endothelialization on stent material surface has been suggested to be the key to reduce
platelet adhesion, stent thrombosis and other adverse outcomes [70,131]. It was shown that
increased endothelial coverage could significantly improve the long-term patency and reduce the
interaction of blood components with artificial implants [9,132,133]. Some studies used L-929
and MG63 cells to test the biocompatibility of Mg alloys [30,34]. Little was known about how
endothelial cells would interact with Mg alloys. In this study, Indirect MTT showed that there
was a decreased cell viability tendency in all groups as the increase of concentrations of extract
solutions. This was most likely due to the higher pH level and degradation products, leading to

64
mitochondrial oxidative stress. It is also interesting that no further decrease in viability were
observed for R1 and R2 on days 4 and 7. In R3 and R4, cell viabilities through all the seven days
were not significantly different from pure Mg, which indicated the release of REs from these two
alloys didn’t affect the HAECs viability. In addition, Figure 14 shows even on the 7th day, more
than half of the cells were still in healthy morphology, which seems to contradict with the 7th day
MTT test. One possible explanation is that extract solution did not cause lethal damage to cell
membranes or genetic substances but only lead to decreased enzymatic activities or altered gene
regulation.
In direct cell attachment test, R1 and R2 had the lowest density of attached cells after 3 h
indicating the surface of those materials were least favorable for cell adhesion and attachment.
This is most likely caused by the combination effect of the presence of Dy and relative higher
degradation rate compared with R3 and R4. As the degradation of R1 and R2 in ECM, Dy ions
may inhibit the attachment of endothelial cells at the initial stage. Also, some swollen cells with
green color were present on R1 and R2 indicating cells were dying though the cell membranes
were still intact, therefore, retaining the green fluorescence. R3 had the comparable cell
attachment and viability with the tissue culture plate control while R4 and pure Mg had moderate
cell attachment. After 24 hours of incubation, most cells were dead on pure Mg and many gas
bubbles emerged. A few live cells could still be observed on R1 and R2, but obviously in
stressed conditions. In contrast, fully spread cells were the major population on R3 and R4
surfaces but the densities were much smaller than that on tissue culture plate. The death of cells
could be mainly caused by increased pH value as the degradation of Mg alloys progressed.
Results demonstrated that all Mg-RE alloys exhibited better endothelialization than pure Mg
control in the static culture environment. It would be totally different in dynamic system or in
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vivo, and we expect that endothelial cells would have much better attachment, survival and
growth in vivo as the dynamic circulation system will remove the degradation products and
prevent the hike of local pH.
5.1.3 Collagen self-assembly on Mg and subsequent cell attachment. Collagen, the
ubiquitous ECM component, is a large family of triple-helical proteins. So far, around 28 types
of collagen have been identified. Among them, type I collagen is the most abundant .It forms the
backbone of ECM in a lot of tissues such as bone, dermis, and tendon. 90 % of the organic
weight of bone is made up of type I collagen [134]. Type I collagen triple helix is composed of
heterotrimer of two identical α1(I) chains and one α2(I) chain. Procollagen molecule is
synthesized inside cells followed by post-translational modifications and then assembles into
triple helix procollagen with diameter of 1.5 nm and length of 300 nm [134]. Then it is secreted
to extracellular space by secretory vesicles and further processed by different proteinases. In
vitro, collagen fibrils are formed by self-assembly into cross-striated fibrils with the
characteristic D-period of 67 nm [135]. In natural bone tissues, collagen fibrils are the scaffold
for biomineralization. It is believed that collagen molecules are secreted as amorphous and noncrystalline forms and then transformed into crystalline forms gradually [136].
Mg-based alloys have promising future for orthopedic applications with respect to their
mechanical properties, degradation properties, and biocompatibility. While the exact mechanism
of collagen fibril formation on Mg surface in vivo remains unknown, in vitro self-assembly
model established in this work provides a simple and alternative way to study how Mg materials
interact with collagen molecules.
Collagen fibril formation on mica surface involves the adsorption of collagen molecules,
surface diffusion, nucleation of fibrils and fibril elongation [137,138]. A lot of studies have

66
shown that collagen could self-assemble into axially aligned fibrils with D-period similar to
native bone tissues [139,140]. However, the assembly of collagen on mica surface could be
different from that on Mg-alloy surface due to their distinct surface characteristics and
electrostatics. Once in contact with body fluid, the metal elements in Mg materials will be
oxidized into metal cations followed by the formation of a layer of metal hydroxide [8]. Metal
ion would be released to the fluid during the degradation process and biomacromolecules such as
protein, proteoglycan, and glycoprotein can be absorbed to the metal hydroxide layer [8]. It is
interesting that for both pure Mg and AZ31 with different surface roughness, Mg ion released to
the collagen solution after 2 h incubation didn’t show significant difference. This is most likely
due to the small total volume of solution (50 µl) and Mg ion was already saturated in the
solution. At neutral pH, this metal hydrochloride layer is beneficial for collagen molecule
adsorption since collagen molecule is positively charged. The absence of large fibril at low
concentration of collagen monomer is most likely caused by the decreased chance for fibril
nucleation. The concentration of collagen monomer can also affect the fibril growth rate and
single fibrils grow independent from each other until they fuse with adjacent fibrils [137]. In
addition, it was shown by Wang et al. that at low concentration collagen monomers form
agglomerates in solution containing excessive Mg ions [141]. Similar agglomerates structure was
also observed here on pure Mg and AZ31 surface at low collagen concentration. This might be
caused by the high Mg2+/collagen ratio and excessive Mg2+ could bind to collagen side chain
leading to the increase of protein hydrophobicity and the dehydration of collagen [142]. Besides
the release of metal ions, pH change accompanying the degradation process is another important
factor that could affect collagen assembly. In the absence of other electrolytes, the isoelectric
point (pI) of collagen is around 9.3 [143]. When pH approximates pI, the surface charge of
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collagen monomers is decreased resulting in minimized electrostatic repulsion and better fibril
assembly. This is supported by our data (Figure 18) where collagen fibrils loosely aligned at pH
of 7 while they formed a dense layer of sheet at pH 9. As pH increased to 11, negatively charged
collagen monomers could inhibit the nucleation of collagen fibril as well as the further
attachment to Mg hydroxide layer. With the increase of incubation time to 8 h, small collagen
fibrils could merge with adjacent fibrils forming thicker fibers (Figure 19C and Figure 19D). It
is interesting to see that in almost all experiments, spherical particles with different size attached
to collagen fibrils irrespective of the diameter of collagen fibrils. The shape and size of those
particles are very similar to the mineral nucleation reported by Ferreia et al [144].
It is well documented that implant surface roughness alters osteoblast proliferation,
differentiation, and extracellular matrix production [145]. Mendonca et al. showed that rough
surface topography can stimulate collagen biosynthesis and accumulation on titanium [146]. Mg
materials with RS have relative larger surface area that increases the chance of collagen
molecules adsorption. This is probably why the amount of collagen absorbed on the RS and SR
materials was significantly higher than that on materials with SS. Also, surface energy could
affect collagen adsorption and structural rearrangement. It is noticeable that the amount of
absorbed collagen decreased at 8 h on the materials with RS and SR. This phenomenon is most
likely caused by severe pitting corrosion on rougher surface compared with smoother surface
[147,148]. In addition, surface roughness not only affected the amount of collagen absorbed but
also the structure of the fibrils. The slight morphological difference of collagen fibrils on Mg and
AZ31 is likely caused by the presence of Zn2+ and Al 3+, the AZ31 degradation products [143].
Enhanced cell attachment on the materials with SS is consistent with previous studies
[149]. On AZ31 material, a lot of dead cells could be observed on the RS materials after the first
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day. This is most likely due to the failure of cell attachment or hampered cell attachment on the
RS where cells could only anchor themselves at reduced area caused by the existence of the
grooves and ridges. The grooves and ridges showed contact guidance effect on cell alignment. It
was demonstrated before that the tip of filopodia most likely attaches to the top of the ridges
[150]. During cell migration, it would be much easier for cell to move the tip of the adhesion
along the ridge than to move the tip of the adhesion perpendicular to the direction of ridges. That
may be the reason why cells on the rough surface materials all aligned parallel to the direction of
ridges. Cells showed similar proliferation results on AZ31 with different surface roughness
indicating that surface roughness and collagen structure will not affect cell proliferation.
However, cells did not show similar proliferation result on pure Mg at 4 th day and 7th day. Cell
density significantly decreased at the Mg with RS and SR. Healthy spreading cells could hardly
be found on the SS pure Mg materials. At body temperature, melting time for human type I
collagen is around several days [151]. Compared with AZ31, the relative faster degradation rate
of pure Mg could lead to higher concentration of degradation products and higher pH in solution,
which might accelerate dissociation of attached collagen and cause decreased cell density. In
addition, the thick collagen ribbon structure doesn’t resemble native collagen structure in bone.
The collagen fibrils in Figure 21C and Figure 21D showed high similarity with the
demineralized circumferential lamellar bone [152]. Ideally, the preferable orthopedic implants
should not only be able to stimulate bone cell growth but also to support the assembly of
collagen monomer into native fibrils at the bone-implant interface.
This in vitro model was developed to mimic the in vivo interactions between collagen
and the Mg implant at the interface. It provided useful information on the molecular mechanism
of such an interaction that will influence the fate of the implant. However, limitations do exist in
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this study . For example, different cell regulations and other protein interactions were neglected.
Other types of bone cells and non-collagenous proteins also play important roles in collagen
assembly [153]. Therefore, future studies are needed to address these factors. Specifically, one
topic could be to investigate how mineralization happens around the interfaces.
5.1.4 Endothelialization of Mg-RE alloys with fluoride conversion coating. Previous
studies have shown that fluoride conversion coating can improve the corrosion resistance of Mg
materials [57,154-157]. Fluorine is essential for human dental development. Mao et al. showed,
that Mg-Nd-Zn-Zr alloy, after treated with HF solution for 12 hours, forms a porous layer of
MgF2 on its surface [57]. It was shown that the bonding strength of interlayer of MgF2 in pure
Mg treated with HF was found to be 34 MPa [158]. Wan et al. also reported a super-hydrophobic
porous surface created by 1% HF treatment [67]. It is believed that the porous structure played
an important role in trapping air, which leads to the hydrophobic surface. The porous structure
with smaller cavities was observed in Figure 27. MgF2 is insoluble in water and the small
cavities among the granular structure were able to trap air. The capability of the HF modified
layer to ameliorate Mg degradation is mainly dependent on the size of those granular structures.
The smaller cavities on the MgF2 layer, the more efficient they were at trapping air.
Another consideration is that MgF2 layer on the material surface might be brittle
according to a previous study [159], thus a modification of the mechanical properties has to be
expected. Therefore, one need be cautious when applying this HF treatment for balloon
expandable stent materials.
Direct endothelialization showed that HF treatment could improve endothelial cell
attachment and proliferation compared with bare material and collagen coated material. Collagen
coating was used as positive control in this study since it is the most abundant extracellular
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matrix protein which provides adhesion points for cell attachment and migration. Ao et al.
showed that type I collagen covalently combined with titanium enhanced cell-material
interactions and improved hMSC attachment, proliferation, and differentiation [160]. In addition,
Collagen-coated Ti could promote expression of osteoblast phenotype and enhance bone
formation around the implants [161]. However, on Mg surface collagen coating didn’t show
much improvement for HCAECs attachment and proliferation. This is probably due to the
different corrosion rate and corrosion mechanism. As the degradation of Mg alloys progressed,
increased pH and excess alloying element ions could affect the 3-D structure of biomolecules,
leading to the failure of recognition between extracellular matrix proteins and the cell membrane
receptors. In addition, hydrogen gas production during the corrosion process could form gas
bubbles on the Mg surface, which may have prevented both biomacromolecule attachment and
cell adhesion.
5.2 Future Research
The cytocompatibility of Mg material degradation products on endothelial cell,
hemocompatibility and endothelialization of Mg-RE alloys, collage self-assembly on bone
orthopedic materials and the endothelializition on fluoride conversion coating Mg materials was
studied in this research project. The findings from this study provide useful information on cellmetal ion interaction and preliminary safety evaluation of Mg-based stent material. Also, Mg
alloying with REs and HF conversion coating could significantly improve the endothelial cell
attachment in vitro showing great potential for clinical application. However, limitations do exist
in each of the studies and there are several aspects that should be address in the future. The
degradation products from stent material are the combination of all the metal elements instead of
the single metal ion tested in this research. Therefore, to study how the mixture of Mg
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degradation products affects cytocompatibility will be the next step for evaluating material
toxicity in vitro. The effect of other factors such as pH change, air bubble formations and metal
debris accompanying the degradation process on cell behavior should also be considered. In
addition, it is also very important to study how those factors affect smooth muscle cell and blood
cells.
The endotheliallization experiments were carried out in a static environment. However, in
vivo, both endothelial cells and stent materials are subjected to blood flow. For this reason, static
endothelialization does not represent the same endothelial behavior or degradation propertied of
Mg stent exposed to blood flow and it is important to simulate the flow condition for endothelial
attachment experiment. For the HF conversion coating, future research should elucidate the
degradation mechanism of MgF2. What kind of finial degradation products this MgF2 layer will
produce and how are those degradation products metabolized by cells? Is there any long-term
toxic effect of fluorine? Those questions should all be answered before the application of HF
coating on stent material. In the collagen self-assembly on bone orthopedic materials, future
work should also include how other molecules in bone tissues, such as some non-collagenous
glycoproteins, hyaluronic acid, chondroitin sulfate and mineral deposition interact with Mg
materials. Besides, it is also unknown how Mg interacts with osteoblasts, osteoclasts and
osteocytes. Those studies would further provide useful information to evaluate Mg-based
orthopedic materials and stent materials.
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